Search For "favipiravir"
Glenmark announces top-line results from phase 3 clinical trial of Favipir
Updated : 2 years, 6 months ago IST
Mumbai (Maharashtra) [India] July 23 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd - a global research-led pharmaceutical company - announced top-line results from a phase 3 clinical trial in mild to moderate COVID-19 patients, conducted across seven clinical sites in India.
Read More
COVID-19: Glenmark's Favipiravir drug shows encouraging results in Phase 3
Updated : 2 years, 6 months ago IST
New Delhi [India], July 22 (ANI): Domestic pharma giant Glenmark pharmaceuticals on Thursday announced the positive outcomes from a Phase 3 clinical trial conducted across seven clinical sites in India, where COVID-19 patients administered with Favipiravir reported faster clinical cure an
Read More
DCGI seeks clarification from Glenmark on its anti-viral favipiravir for u
Updated : 2 years, 6 months ago IST
New Delhi [India], July 19 (ANI): The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on COVID-19 patients with comorbidities.
Read More
Glenmark cuts COVID-19 drug Favipiravir price by 27 pc
Updated : 2 years, 6 months ago IST
Mumbai (Maharashtra) [India], July 13 (ANI): Glenmark Pharmaceuticals said on Monday it has cut the price of its anti-viral drug Favipiravir under the brand name FabiFlu for treatment of patients with mild to moderate COVID-19 by 27 per cent to Rs 75 per tablet.
Read More
Glenmark, Cipla stocks surge after nod to launch drugs for mild-to-moderat
Updated : 2 years, 7 months ago IST
Mumbai (Maharashtra) [India], June 22 (ANI): Glenmark Pharmaceuticals' share price surged 30 per cent on Monday to Rs 531.80 per unit after it became the first pharmaceutical company in India to receive regulatory approval to make and sell oral antiviral drug favipiravir for treating mild-to
Read More
Anti-viral drug Favipiravir shows clinical improvement in mild, moderate C
Updated : 2 years, 7 months ago IST
New Delhi [India], June 20 (ANI): Domestic pharmaceuticals Glenmark on Saturday informed that their antiviral drug -- Favipiravir -- has shown clinical improvement of up to 88 per cent in mild to moderate COVID-19 cases, including those with co-morbidities.
Read More
Anti-viral drug favipiravir gets DGCI nod for 'restricted emergency use' i
Updated : 2 years, 7 months ago IST
New Delhi [India], June 19 (ANI): The Drug Controller General of India (DCGI) has granted permission to anti-viral drug favipiravir for "restricted emergency use" in mild to moderate cases of COVID-19, a senior government official confirmed to ANI.
Read More
Centre brings fresh rules for import of unapproved new drug for 'compassio
Updated : 2 years, 7 months ago IST
New Delhi [India], June 8 (ANI): The Union Health Ministry has drafted the new rules for import of unapproved new drug for only 'compassionate Use' for treatment of patients by hospitals or medical institutions under New Drugs and Clinical Trials Rules, 2019.
Read More
Glenmark to start new phase 3 clinical trial for hospitalised patients of
Updated : 2 years, 8 months ago IST
Mumbai (Maharashtra) [India], May 26 (ANI): Glenmark Pharmaceuticals on Tuesday announced a new randomised, open-label study to test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential Covid-19 treatment strategy.
Read More
Combating COVID-19: CSIR working on 10 different vaccines, drug trials
Updated : 2 years, 8 months ago IST
New Delhi [India], May 21 (ANI): Three drug trials to combat COVID-19 have started and seven are in the process, said Council of Scientific and Industrial Research (CSIR) Director-General (DG) Dr Shekhar C Mande on Thursday.
Read More
'Govt still not satisfied with the efficacy of antiviral drugs Remdesivir,
Updated : 2 years, 8 months ago IST
New Delhi [India], May 15 (ANI): The Union Health Ministry is still not satisfied with the efficacy of two antiviral drugs--Remdesivir and Favipiravir--for the treatment of COVID-19 patients.
Read More
Glenmark begins phase 3 of clinical trials on antiviral Favipiravir for CO
Updated : 2 years, 8 months ago IST
Mumbai (Maharashtra) [India], May 12 (ANI): Glenmark Pharmaceuticals has initiated phase three of clinical trials in India on antiviral tablet Favipiravir, becoming the first company in the country to do so.
Read More